Key facts
- This page summarizes Amit Sachdev's Form 4 filing for VERTEX PHARMACEUTICALS INC / MA (VRTX).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Feb 2022, 15:24.
Amit Sachdev - 01 Feb 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)
- Reporting relationship
- EVP, Chief Patient Officer
- Issuer ticker
- VRTX
- Reported as of
- 01 Feb 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Feb 2022, 15:24:11 UTC
- Prior SEC filing
- 16 Nov 2021
- Next SEC filing
- 14 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sabrina Yohai, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Amit Sachdev filed Form 4 for VERTEX PHARMACEUTICALS INC / MA (VRTX) on 03 Feb 2022.
Change
- Previous filing in this sequence was filed on 16 Nov 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VRTX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +9,800
- Change %
- +31%
- Price
- $0.000000
- Shares after
- 41,728
- Date
- 01 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
VRTX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +11,628
- Change %
- +28%
- Price
- $0.000000
- Shares after
- 53,356
- Date
- 01 Feb 2022
- Ownership
- Direct
- Footnotes
- F2
VRTX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +8,210
- Change %
- +15%
- Price
- $0.000000
- Shares after
- 61,566
- Date
- 01 Feb 2022
- Ownership
- Direct
- Footnotes
- F3
VRTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 882
- Date
- 01 Feb 2022
- Ownership
- 401(k)
VRTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 15,573
- Date
- 01 Feb 2022
- Ownership
- Held in Trust
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2022 and the shares will vest on 02/24/2022.
Footnote F2
Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2022 and the shares will vest in installments beginning on 02/17/2022.
Footnote F3
Restricted stock unit award that vests in installments beginning on 02/24/2023.
SEC remarks
Exhibit 24 - Power of Attorney